Tandem Diabetes Care (TNDM) Tax Rate (2018 - 2026)
Tandem Diabetes Care (TNDM) posted Tax Rate of 2.51% for Q1 2026, down 102.25% on a QoQ basis from 111.48% in Q4 2025, and up 445.0% year-over-year from 0.46% in Q1 2025.
Tandem Diabetes Care (TNDM) Tax Rate (2018 - 2026) Analysis & Trends
Tandem Diabetes Care's Tax Rate history runs 9 years deep, the most recent figure standing at 2.51% for Q1 2026.
- Quarterly Tax Rate rose 445.0% year-over-year to 2.51% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 3.58% (up 898.0% YoY) and the FY2025 annual result came in at 2.22%, up 231.0% from the prior year.
- Tax Rate was 2.51% for Q1 2026 at Tandem Diabetes Care, down from 111.48% in the prior quarter.
- Across five years, Tax Rate topped out at 111.48% in Q4 2025 and bottomed at 4618.75% in Q4 2024.
- A 5-year average of 265.9% and a median of 2.65% in 2024 frame the typical range for Tax Rate.
- Annual changes were most pronounced in 2024 — Tax Rate plunged 462304 bps — and 2025, when it soared 473023 bps.
- Tandem Diabetes Care's Tax Rate stood at 1.62% in 2022, then soared by 165 bps to 4.29% in 2023, then slumped by 107779 bps to 4618.75% in 2024, then jumped by 102 bps to 111.48% in 2025, then sank by 102 bps to 2.51% in 2026.
- Business Quant data shows TNDM's Tax Rate at 2.51% in Q1 2026, 111.48% in Q4 2025, and 15.82% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 25.67% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.35% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 31.35% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -15.15% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 17.06% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 25.97% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -23.16% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 18.61% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Tandem Diabetes Care | 1.16 Bn | 587.46 Mn | 136.79 Mn | -2.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.51% |
| Mar 31, 2026 | -2.51% |
| Mar 31, 2026 | -2.51% |
| Dec 31, 2025 | 111.48% |
| Dec 31, 2025 | 111.48% |
| Dec 31, 2025 | 111.48% |
| Sep 30, 2025 | 15.82% |
| Sep 30, 2025 | 15.82% |
| Sep 30, 2025 | 15.82% |
| Jun 30, 2025 | 9.18% |
| Jun 30, 2025 | 9.18% |
| Jun 30, 2025 | 9.18% |
| Mar 31, 2025 | -6.96% |
| Mar 31, 2025 | -6.96% |
| Mar 31, 2025 | -6.96% |
| Dec 31, 2024 | -4,618.75% |
| Dec 31, 2024 | -4,618.75% |
| Dec 31, 2024 | -4,618.75% |
| Sep 30, 2024 | -2.65% |
| Sep 30, 2024 | -2.65% |